Join our expert-led panel to explore innovative formulation strategies, the diverse mechanisms of action, preclinical and clinical considerations, as well as encapsulation techniques, and more.
Summary: Catalent President and CEO Alessandro Maselli sits down with Endpoints News founder John Carroll to discuss the evolving role of CDMOs and what’s next for Catalent as it progresses with its shift from public to private ownership under its previously announced transaction with Novo Holdings.
Summary: In this webinar, industry experts will discuss how a manufacturing on-demand strategy can enhance your clinical development and improve drug supply utilization.
Summary: In this webinar, experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.
Industry experts discuss how QbD strategies can be applied in the systematic evaluation of small batches of spray-dried solid dispersions for oral delivery.
